• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HE Ting,XIE Xiaowen,LIU Xiaoyan,LI Shengjun,TU Qidong.Research progress of polypyridine metal anticancer drugs[J].Journal Of Pharmaceutical Research,2024,43(7):694-701[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3414times   Download 4116次 QR Code for this article
Scan with your phone!
多吡啶金属抗癌药物的研究进展
何婷1,2,谢孝文3,刘晓燕1,2,李圣俊1,2,涂其冬1,2
Font:Larger+|Default|Smaller-
(1.江西科技师范大学药学院,江西 南昌 330013;2.江西省药物分子设计与评价重点实验室,江西 南昌 330013;3.中国林业科学研究院林产化学工业研究所,江苏 南京 210042)
摘要:
癌症严重威胁人类的健康。多吡啶金属配合物具有特殊的几何结构和配位特性,能通过静电相互作用、插层、凹槽结合等方法与DNA、蛋白质等生物大分子结合,表现出较好的抗菌和抗癌活性,也具有特殊的靶向治疗特性。此外,通过改变或修饰配体,可调整配合物的功能,并且能够单独作用在线粒体、溶酶体等细胞器上与特定生物分子相互作用。本文概述了近年来用于癌症治疗的多吡啶金属配合物的研究进展,为新型抗癌药物的研发提供更多思路。
关键词:  金属配合物  多吡啶配体  靶向治疗  抗癌药物
DOI:10.13506/j.cnki.jpr.2024.07.013
基金项目:江西省药物分子设计与评价重点实验室开放课题(No.JKLDE0KF-2204);江西省高等学校精细化学品工程技术研究中心开放课题(No.JFCEC-KF-2201);江西科技师范大学大学生创新创业训练计划项目(No.20231704208、20231704206)
Publication Date:July 25, 2024
Research progress of polypyridine metal anticancer drugs
HE Ting1,2,XIE Xiaowen3,LIU Xiaoyan1,2,LI Shengjun1,2,TU Qidong1,2
(1.School of Pharmacy, Jiangxi Science and Technology Normal University, Nanchang 330013,China;2.Jiangxi Provincial Key Laboratory of Drug Design and Evaluation,Nanchang 330013,China;3.Institute of Chemical Industry of Forest Products, Chinese Academy of Forestry (CAF),Nanjing 210042,China)
Abstract:
Cancer has caused great harm to human health. The targeted therapy strategy of polypyridine metal complexes has a good performance due to its special geometric structure and coordination characteristics, which can be combined with DNA, protein and other biological macromolecules through electrostatic interaction, intercalation, groove binding and other methods, showing good antibacterial and anticancer activities. In addition, by changing the ligands or modifying the ligands, the function of the complexes can be adjusted, and it can act alone on mitochondria, lysosomes and other organelles to interact with specific biomolecules. This article summarizes the research progress of polypyridine metal complex drugs for cancer treatment in recent years, in order to provide more ideas for the development of new anticancer drugs.
Key words:  Metal complexes  Polypyridine ligand  Targeted therapy  Anticancer drugs
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.